Cost Communication and Financial Navigation in Cancer Patients (COSTCOM) (NCT06295367)

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

1. NON-PATIENTS PARTICIPANTS: Participant must speak English
2. NON-PATIENTS PARTICIPANTS: Participant must be employed at National Cancer Institute Community Oncology Research Program (NCORP) site for at least six months
3. NON-PATIENTS PARTICIPANTS: Participant must be able to provide informed consent to participate in this study
4. NON-PATIENTS PARTICIPANTS: Participant must be one of the following:
5. A study coordinator with a role involving use of CostCOM intervention price transparency and financial navigation platform
6. A practice oncology provider (i.e., physician or mid-level), or
7. A practice financial counselor, social workers, financial navigators, or pharmacist who have provided care or been in contact (in the last 3 months) to a patient who was assigned to the CostCOM arm, and who completed the at least 6 month study follow-up
8. PATIENT ELIGIBILITY CRITERIA FOR STEP 0 (OPEN SCREENING REGISTRATION): Patient must be ≥ 18 years of age
9. PATIENT ELIGIBILITY CRITERIA FOR STEP 0 (OPEN SCREENING REGISTRATION): Patient must be fluent in written and spoken English OR patient must be fluent in written and spoken Spanish
10. PATIENT ELIGIBILITY CRITERIA FOR STEP 0 (OPEN SCREENING REGISTRATION): Patient must be within 120 days of a new diagnosis of any solid cancer of any stage at the time of Step 0
11. PATIENT ELIGIBILITY CRITERIA FOR STEP 0 (OPEN SCREENING REGISTRATION): Patient must have had their first medical oncology visit at the time of Step 0
12. PATIENT ELIGIBILITY CRITERIA FOR STEP 0 (OPEN SCREENING REGISTRATION): Patient must have initiated oral or intravenous (IV) cancer systemic therapy or have received a prescription order with stated intent to initiate within 30 days following Step 0 consent

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (391 Sites)

• Anchorage Associates in Radiation Medicine — Anchorage, Alaska
• Alaska Breast Care and Surgery LLC — Anchorage, Alaska
• Alaska Oncology and Hematology LLC — Anchorage, Alaska
• Alaska Women's Cancer Care — Anchorage, Alaska
• Katmai Oncology Group — Anchorage, Alaska
• Providence Alaska Medical Center — Anchorage, Alaska
• Fairbanks Memorial Hospital — Fairbanks, Alaska
• Kingman Regional Medical Center — Kingman, Arizona
• Mercy Hospital Fort Smith — Fort Smith, Arkansas
• NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro — Jonesboro, Arkansas
• CARTI Cancer Center — Little Rock, Arkansas
• PCR Oncology — Arroyo Grande, California
• Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California
• Contra Costa Regional Medical Center — Martinez, California
• Providence Queen of The Valley — Napa, California
• Providence Medical Foundation - Santa Rosa — Santa Rosa, California
• Providence Santa Rosa Memorial Hospital — Santa Rosa, California
• BASS Medical Group - Lennon — Walnut Creek, California
• Rocky Mountain Cancer Centers-Aurora — Aurora, Colorado
• Boulder Community Foothills Hospital — Boulder, Colorado
• Rocky Mountain Cancer Centers-Boulder — Boulder, Colorado
• Rocky Mountain Cancer Centers - Centennial — Centennial, Colorado
• The Women's Imaging Center — Denver, Colorado
• Colorado Blood Cancer Institute — Denver, Colorado
• Presbyterian - Saint Lukes Medical Center - Health One — Denver, Colorado

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.